H.R.1730: Cancer Drug Parity Act of 2019

About This Bill

Bill Cosponsors

170 (105 Democrats, 65 Republicans)

Bill Version

Bill Summary

Cancer Drug Parity Act of 2019 This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 2 statements associated with H.R.1730.

Bill Actions

Date Description
March 14, 2019
Referred to the Subcommittee on Health.
March 13, 2019
Referred to the House Committee on Energy and Commerce.
March 13, 2019

Introduced in the House by Brian Higgins (D-N.Y.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page